Definitive Selection of Neuroimaging Biomarkers in Anxiety Disorder and Obsessive-compulsive Disorder: A Longitudinal Functional Magnetic Resonance Imaging （fMRI） Study With Paroxetine Treatment

NCT03894085 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Anxiety Disorder
Obsessive-Compulsive Disorder

Interventions

DRUG: Paroxetine

Sponsor

Central South University